The replication of the association of the rs6832151 within chromosomal band 4p14 with Graves' disease in a Polish Caucasian population

Tissue Antigens

Volumn 79, Issue 5, 2012, Pages 380-383

  Szymanski K ^a   Bednarczuk, T ^a,b   Krajewski, P ^a   Ploski R ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

4p14; 6q27; Association; Autoimmune disease; Graves' disease; Ophthalmopathy; Poland; Rs6832151; Rs9355610; Single nucleotide polymorphism

Indexed keywords

GENOMIC DNA; LYMPHOCYTE ANTIGEN;

ADULT; ALLELE; ARTICLE; CAUCASIAN; CHROMOSOME 4Q; CHROMOSOME BAND; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLISH CAUCASIAN; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 4; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GRAVES DISEASE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 84859590499     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2012.01854.x     Document Type: Article

References (22)

1. Płoski R, Szymański K, Bednarczuk T. The genetic basis of Graves' disease. Curr Genomics 2011: 12: 542-63.
2. Chu X, Pan CM, Zhao SX et al. A genome-wide association study identifies two new risk loci for Graves' disease. Nat Genet 2011: 43: 897-901.
3. Kisiel B, Bednarczuk T, Kostrzewa G et al. Polymorphism of the oestrogen receptor beta gene (ESR2) is associated with susceptibility to Graves' disease. Clin Endocrinol (Oxf) 2008: 68: 429-34.
4. Skorka A, Bednarczuk T, Bar-Andziak E, Nauman J, Ploski R. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset. Clin Endocrinol (Oxf) 2005: 62: 679-82.
5. Mueller-Malesinska M, Nowak M, Ploski R, Waligora J, Korniszewski L. Epidemiology of 35delG mutation in GJB2 gene in a Polish population. J Audiologic Med 2001: 10: 136-41.
6. Kavvoura FK, Akamizu T, Awata T et al. Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. J Clin Endocrinol Metab 2007: 92: 3162-70.
7. Ploski R, Brand OJ, Jurecka-Lubieniecka B et al. Thyroid stimulating hormone receptor (TSHR) intron 1 variants are major risk factors for Graves' disease in three European Caucasian cohorts. PLoS ONE 2010: 5: e15512.
8. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
9. Chen PL, Fann CS-J, Chu CC et al. Comprehensive genotyping in two homogeneous Graves' disease samples reveals major and novel HLA association alleles. PLoS ONE 2011: 6: e16635.
10. Curwen V, Eyras E, Andrews TD et al. The Ensembl automatic gene annotation system. Genome Res 2004: 14: 942-50.
11. Via M, Gignoux C, Burchard EG. The 1000 Genomes Project: new opportunities for research and social challenges. Genome Med 2010: 2: 3.
12. Koval L, Lykhmus O, Zhmak M et al. Differential involvement of alpha4beta2, alpha7 and alpha9alpha10 nicotinic acetylcholine receptors in B lymphocyte activation in vitro. Int J Biochem Cell Biol 2011: 43: 516-24.
13. Kurylowicz A, Kula D, Ploski R et al. Association of CD40 gene polymorphism (C-1T) with susceptibility and phenotype of Graves' disease. Thyroid 2005: 15: 1119-24.
14. Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y. Association of a C/T single-nucleotide polymorphism in the 5' untranslated region of the CD40 gene with Graves' disease in Japanese. Thyroid 2006: 16: 443-6.
15. Tomer Y, Concepcion E, Greenberg DA. A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 2002: 12: 1129-35.
16. Houston FA, Wilson V, Jennings CE et al. Role of the CD40 locus in Graves' disease. Thyroid 2004: 14: 506-9.
17. Jacobson EM, Concepcion E, Oashi T, Tomer Y. A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology 2005: 146: 2684-91.
18. Hsiao JY, Hsieh MC, Hsiao CT, Weng HH, Ke DS. Association of CD40 and thyroglobulin genes with later-onset Graves' disease in Taiwanese patients. Eur J Endocrinol 2008: 159: 617-21.
19. Kochi Y, Okada Y, Suzuki A et al. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat Genet 2010: 42: 515-9.
20. Quan C, Ren YQ, Xiang LH et al. Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC. Nat Genet 2010: 42: 614-8.
21. Birlea SA, Gowan K, Fain PR, Spritz RA. Genome-wide association study of generalized vitiligo in an isolated European founder population identifies SMOC2, in close proximity to IDDM8. J Invest Dermatol 2010: 130: 798-803.
22. Bradfield JP, Qu HQ, Wang K et al. A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci. PLoS Genet 2011: 7: e1002293.